Cohesion Medical Limited Filleted Accounts Cover
Cohesion Medical Limited
Company No. SC428416
Information for Filing with The Registrar
31 December 2024
Cohesion Medical Limited Balance Sheet Registrar
at
31 December 2024
Company No.
SC428416
Notes
2024
2023
£
£
Fixed assets
Intangible assets
5
487,340208,924
Tangible assets
6
2,7054,255
490,045213,179
Current assets
Debtors
7
86,18777,169
Cash at bank and in hand
15,55317,483
101,74094,652
Creditors: Amount falling due within one year
8
(228,052)
(135,242)
Net current liabilities
(126,312)
(40,590)
Total assets less current liabilities
363,733172,589
Creditors: Amounts falling due after more than one year
9
(93,585)
-
Provisions for liabilities
Deferred taxation
10
(54,702)
(41,054)
Net assets
215,446131,535
Capital and reserves
Called up share capital
61,26061,260
Share premium account
11
597,170597,170
SAFE notes
11
300,000
285,000
Profit and loss account
11
(742,984)
(811,895)
Total equity
215,446131,535
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 22 January 2025
And signed on its behalf by:
K. Sangha
Director
22 January 2025
Cohesion Medical Limited Notes to the Accounts Registrar
for the year ended 31 December 2024
1
General information
Its registered number is: SC428416
Its registered office is:
The Hub
Pacific Quay
Glasgow
G51 1DZ
The functional and presentational currency of the company is Sterling. The accounts are rounded to the nearest pound.
The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
2
Accounting policies
Turnover
Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Revenue from the sale of goods is recognised when all the following conditions are satisfied:
• the Company has transferred to the buyer the significant risks and rewards of ownership of the
goods;
• the Company retains neither continuing managerial involvement to the degree usually associated
with ownership nor effective control over the goods sold;
• the amount of revenue can be measured reliably;
• it is probable that the economic benefits associated with the transaction will flow to the Company;
and
• the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.
Intangible fixed assets
Intangible fixed assets are carried at cost less accumulated amortisation and impairment losses. Development costs are amortised over 5 years. Patents& trademarks are amortised over 10 years.
Tangible fixed assets and depreciation
Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
Furniture, fittings and equipment
20% Straight Line
Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Defined contribution pensions
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations.
The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.
3
Change in length of the reporting period
The length of the reporting period in 2023 was 9 months to realign with business operations. The reporting period in 2024 is 12 months. Therefore the comparatives are not comparable.
4
Employees
2024
2023
Number
Number
The average monthly number of employees (including directors) during the year was:
88
5
Intangible fixed assets
Patents and trade-marks
Develop-ment costs
Total
£
£
£
Cost
At 1 January 2024
12,007241,965253,972
Additions
-328,000328,000
At 31 December 2024
12,007569,965581,972
Amortisation and impairment
At 1 January 2024
8,75336,29545,048
Charge for the year
1,20048,38449,584
At 31 December 2024
9,95384,67994,632
Net book values
At 31 December 2024
2,054485,286487,340
At 31 December 2023
3,254205,670208,924
6
Tangible fixed assets
Fixtures, fittings and equipment
Total
£
£
Cost or revaluation
At 1 January 2024
17,65117,651
Additions
249249
At 31 December 2024
17,90017,900
Depreciation
At 1 January 2024
13,39613,396
Charge for the year
1,7991,799
At 31 December 2024
15,19515,195
Net book values
At 31 December 2024
2,7052,705
At 31 December 2023
4,2554,255
7
Debtors
2024
2023
£
£
Trade debtors
-9,377
Corporation tax recoverable
80,69560,587
Other debtors
5,4926,552
Prepayments and accrued income
-653
86,18777,169
8
Creditors:
amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
10,54729,802
Other loans
30,0002,500
Other taxes and social security
9,84411,377
Loans from directors
151,00090,000
Other creditors
1,6611,265
Accruals and deferred income
25,000298
228,052135,242
9
Creditors:
amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
8,585-
Other loans
85,000-
93,585-
10
Provisions for liabilities
Deferred taxation
Accelerated Capital Allowances, Losses and Other Timing Differences
Total
£
£
At 1 January 2024
41,054
41,054
Charge to the profit and loss account for the period
13,648
13,648
At 31 December 2024
54,702
54,702
2024
2023
£
£
Other timing differences
54,70241,054
54,70241,054
11
Reserves
Share premium account - includes any premiums received on issue of share capital. Any transaction costs associated with the issuing of shares are deducted from share premium.
Profit and loss account - includes all current and prior period retained profits and losses.
SAFE notes - these are classified as equity in the balance sheet and will convert into a class of Ordinary Shares at the point the Company raises new equity financing in the future.
Cohesion Medical LimitedSC42841631 December 202401 January 2024false22 January 2025BTCSoftware AP Solution 2024 11.2.0111.2.01trueSC4284162024-01-012024-12-31SC4284162024-12-31SC4284162023-12-31SC428416core:WithinOneYear2024-12-31SC428416core:WithinOneYear2023-12-31SC428416core:AfterOneYear2024-12-31SC428416core:AfterOneYear2023-12-31SC428416core:ShareCapital2024-12-31SC428416core:ShareCapital2023-12-31SC428416core:SharePremium2024-12-31SC428416core:SharePremium2023-12-31SC428416core:RetainedEarningsAccumulatedLosses2024-12-31SC428416core:RetainedEarningsAccumulatedLosses2023-12-31SC428416bus:RegisteredOffice2024-01-012024-12-31SC428416core:FurnitureFittingsToolsEquipment2024-01-012024-12-31SC4284162023-04-012023-12-31SC428416core:PatentsTrademarksLicencesConcessionsSimilar2024-01-01SC428416core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-01SC4284162024-01-01SC428416core:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-31SC428416core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-01-012024-12-31SC428416core:PatentsTrademarksLicencesConcessionsSimilar2024-12-31SC428416core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-31SC428416core:PatentsTrademarksLicencesConcessionsSimilar2023-12-31SC428416core:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-31SC428416core:FurnitureFittingsToolsEquipment2024-01-01SC428416core:FurnitureFittingsToolsEquipment2024-12-31SC428416core:FurnitureFittingsToolsEquipment2023-12-31SC428416core:OtherDeferredTax2024-12-31SC428416core:OtherDeferredTax2023-12-31SC428416core:SharePremium2024-01-012024-12-31SC428416core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31SC428416bus:SmallEntities2024-01-012024-12-31SC428416bus:FullAccounts2024-01-012024-12-31SC428416bus:AuditExempt-NoAccountantsReport2024-01-012024-12-31SC428416bus:Director32024-01-012024-12-31SC428416bus:PrivateLimitedCompanyLtd2024-01-012024-12-31iso4217:GBPxbrli:pure